Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Chronic Heart Failure

  Free Subscription


19.02.2018

1 Am Heart J
1 Circ Heart Fail
1 Circ Res
1 Circulation
1 Eur Heart J
19 Eur J Heart Fail
2 Heart
3 Int J Cardiol
1 J Am Coll Cardiol
5 N Engl J Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am Heart J

  1. SULLIVAN LT 2ND, Randolph T, Merrill P, Jackson LR 2nd, et al
    Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction.
    Am Heart J. 2018;197:43-52.
    PubMed     Text format     Abstract available


    Circ Heart Fail

  2. SHAH R, Ziegler O, Yeri A, Liu X, et al
    MicroRNAs Associated With Reverse Left Ventricular Remodeling in Humans Identify Pathways of Heart Failure Progression.
    Circ Heart Fail. 2018;11:e004278.
    PubMed     Text format     Abstract available


    Circ Res

  3. PACKER M
    Do Dipeptidyl Peptidase-4 Inhibitors Cause Heart Failure Events by Promoting Adrenergically-Mediated Cardiotoxicity? Clues from Laboratory Models and Clinical Trials.
    Circ Res. 2018 Feb 7. pii: CIRCRESAHA.118.312673.
    PubMed     Text format     Abstract available


    Circulation

  4. ZHOU L, Miao K, Yin B, Li H, et al
    The Cardioprotective Role of Myeloid-derived Suppressor Cells in Heart Failure.
    Circulation. 2018 Feb 1. pii: CIRCULATIONAHA.117.030811.
    PubMed     Text format     Abstract available


    Eur Heart J

  5. CLELAND JGF, Mueller C
    What can we learn from SOCRATES: more questions than answers?
    Eur Heart J. 2017;38:1128-1131.
    PubMed     Text format    


    Eur J Heart Fail

  6. ZANNAD F
    Monitoring renal safety in mineralocorticoid receptor antagonist trials.
    Eur J Heart Fail. 2017;19:466-468.
    PubMed     Text format    

  7. SOMMER A, Kronborg MB, Nielsen JC
    Guided left ventricular lead placement for cardiac resynchronization therapy - an opportunity for image integration: reply.
    Eur J Heart Fail. 2017;19:1344.
    PubMed     Text format    

  8. CHEEMA BS, Sabbah HN, Greene SJ, Gheorghiade M, et al
    Protein turnover in the failing heart: an ever-changing landscape.
    Eur J Heart Fail. 2017;19:1218-1221.
    PubMed     Text format    

  9. TAVAZZI L
    A brief overview of cardiac resynchronization therapy and its current use in clinical practice.
    Eur J Heart Fail. 2017;19:1280-1283.
    PubMed     Text format    

  10. MOGENSEN UM, Gong J, Jhund PS, Shen L, et al
    Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1139.
    PubMed     Text format     Abstract available

  11. BALLIGAND JL
    Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning.
    Eur J Heart Fail. 2017;19:576-578.
    PubMed     Text format    

  12. SENNI M, Ferrero P, Iacovoni A
    Prognostic scores: one fits all?
    Eur J Heart Fail. 2017;19:588.
    PubMed     Text format    

  13. BORIANI G, Malavasi VL
    Patient outcome after implant of a cardioverter defibrillator in the 'real world': the key role of co-morbidities.
    Eur J Heart Fail. 2017;19:387-390.
    PubMed     Text format    

  14. VAN LINTHOUT S, Tschope C
    Lost in markers? Time for phenomics and phenomapping in dilated cardiomyopathy.
    Eur J Heart Fail. 2017;19:499-501.
    PubMed     Text format    

  15. TAMPAKAKIS E, Tedford RJ
    Balancing the positives and negatives of the diastolic pulmonary gradient.
    Eur J Heart Fail. 2017;19:98-100.
    PubMed     Text format    

  16. BEHAR JM, Rajani R, Rinaldi CA
    Guided left ventricular lead placement for cardiac resynchronization therapy: an opportunity for image integration.
    Eur J Heart Fail. 2017;19:435.
    PubMed     Text format    

  17. LORUSSO R
    Are two crutches better than one? The ongoing dilemma on the effects and need for left ventricular unloading during veno-arterial extracorporeal membrane oxygenation.
    Eur J Heart Fail. 2017;19:413-415.
    PubMed     Text format    

  18. EL-BATTRAWY I, Borggrefe M, Akin I
    Predictors of mortality in Takotsubo cardiomyopathy.
    Eur J Heart Fail. 2017;19:158.
    PubMed     Text format    

  19. LUND LH, Claggett B, Liu J, Lam CS, et al
    Heart failure with mid-range ejection fraction in CHARM: characteristics, outcomes and effect of candesartan across the entire ejection fraction spectrum.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1149.
    PubMed     Text format     Abstract available

  20. ZYMLINSKI R, Biegus J, Sokolski M, Siwolowski P, et al
    Increased blood lactate is prevalent and identifies poor prognosis in patients with acute heart failure without overt peripheral hypoperfusion.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1156.
    PubMed     Text format     Abstract available

  21. AKIYAMA E, Van Aelst LNL, Arrigo M, Lassus J, et al
    East Asia may have a better 1-year survival following an acute heart failure episode compared with Europe: results from an international observational cohort.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1152.
    PubMed     Text format    

  22. KONSTANTINIDES SV
    Trends in pregnancy outcomes in patients with pulmonary hypertension: still a long way to go.
    Eur J Heart Fail. 2016;18:1129-31.
    PubMed     Text format    

  23. MADIAS JE
    Heart-brain interactions in patients with heart failure, including takotsubo syndrome: a need to monitor autonomic sympathetic activity.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1150.
    PubMed     Text format    

  24. LEVY WC, Dardas TF
    Comparison of cardiopulmonary-based risk models with a clinical heart failure risk model.
    Eur J Heart Fail. 2018 Feb 12. doi: 10.1002/ejhf.1164.
    PubMed     Text format    


    Heart

  25. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    

  26. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed     Text format    


    Int J Cardiol

  27. CHOY JS, Leng S, Acevedo-Bolton G, Shaul S, et al
    Efficacy of intramyocardial injection of Algisyl-LVR for the treatment of ischemic heart failure in swine.
    Int J Cardiol. 2018;255:129-135.
    PubMed     Text format     Abstract available

  28. TIMMERMANS I, Denollet J, Pedersen SS, Meine M, et al
    Patient-reported causes of heart failure in a large European sample.
    Int J Cardiol. 2018 Feb 6. pii: S0167-5273(17)34169.
    PubMed     Text format     Abstract available

  29. AIMO A, Vergaro G, Barison A, Maffei S, et al
    Sex-related differences in chronic heart failure.
    Int J Cardiol. 2018;255:145-151.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  30. ROCHA BML, Cunha GJL, Menezes Falcao LF
    The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
    J Am Coll Cardiol. 2018;71:782-793.
    PubMed     Text format     Abstract available


    N Engl J Med

  31. RESSLER KJ
    Alpha-Adrenergic Receptors in PTSD - Failure or Time for Precision Medicine?
    N Engl J Med. 2018;378:575-576.
    PubMed     Text format    

  32. BERCZELLER PH
    Diuretic Treatment in Heart Failure.
    N Engl J Med. 2018;378:683.
    PubMed     Text format    

  33. SCHRANZ D
    Diuretic Treatment in Heart Failure.
    N Engl J Med. 2018;378:683.
    PubMed     Text format    


  34. Diuretic Treatment in Heart Failure.
    N Engl J Med. 2018;378:683-685.
    PubMed     Text format    

  35. TUTTOLOMONDO A, Parrinello G, Pinto A
    Diuretic Treatment in Heart Failure.
    N Engl J Med. 2018;378:683-4.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: